News
Roche's Lymphoma Drug With Chemo Extends Survival In Pretreated Patients
15 Apr 24
Biotech, News, Health Care, Top Stories, General
HC Wainwright & Co. Reiterates Buy on Repare Therapeutics, Maintains $10 Price Target
8 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Recap: Repare Therapeutics Q4 Earnings
28 Feb 24
Earnings
HC Wainwright & Co. Reiterates Buy on Repare Therapeutics, Maintains $10 Price Target
21 Feb 24
News, Price Target, Reiteration, Analyst Ratings
HC Wainwright & Co. Maintains Buy on Repare Therapeutics, Lowers Price Target to $10
14 Feb 24
News, Price Target, Analyst Ratings
Roche Terminates Cancer Drug Pact With Repare Therapeutics, Its Second Walkout Within A Month
13 Feb 24
Biotech, Large Cap, News, Health Care, Contracts, General
Repare Therapeutics To Regain Global Development, Commercialization Rights To Camonsertib (RP-3500), As Roche Notified That, Effective May 7, 2024, It Is Terminating License And Collaboration Agreement
12 Feb 24
News
Press releases
Repare Therapeutics Inc. (RPTX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
15 Mar 24
Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Repare Therapeutics Inc. - RPTX
7 Mar 24
News, Legal, Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Repare Therapeutics Inc. - RPTX
3 Mar 24
Press Releases
Repare Therapeutics to Participate in Two Upcoming Investor Conferences
29 Feb 24
Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Repare Therapeutics Inc. - RPTX
28 Feb 24
News, Legal, Press Releases
Repare Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
28 Feb 24
Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Repare Therapeutics Inc. - RPTX
24 Feb 24
Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Repare Therapeutics Inc. - RPTX
21 Feb 24
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Repare Therapeutics Inc. - RPTX
21 Feb 24
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Repare Therapeutics Inc. - RPTX
21 Feb 24
REPARE ALERT: Bragar Eagel & Squire, P.C. is Investigating Repare Therapeutics Inc. on Behalf of Repare Stockholders and Encourages Investors to Contact the Firm
20 Feb 24
News, Legal, Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Repare Therapeutics Inc. - RPTX
20 Feb 24
News, Legal, Press Releases
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Repare Therapeutics Inc. (RPTX)
16 Feb 24
Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Repare Therapeutics Inc. - RPTX
15 Feb 24
Press Releases